Keim, Paul Stephen
- Northern Arizona University (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,913
- Rising Star
- Sustained Excellence
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.9M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#1,913
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Keim, Paul Stephen as a PI. Multi-PI records show the full award amount for context.
- 5U19AI166058-02U19Contact PIEarly in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis$1.5Maward amount
- 3U19AI166058-02S1U19Contact PIEarly in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis$1.4Maward amount
Award organization
Organizations that administered FY2023 awards listing Keim, Paul Stephen as a PI.
FY2023 award administered by Northern Arizona University (AZ).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardNorthern Arizona University
- 2006$500K Cumulative Funding
- 2007$1M Cumulative Funding
- 2007$2M Cumulative Funding
- 2007Entered Top 50% NationallyRanked #4002
- 2007Entered Top 25% NationallyRanked #4002
- 2009$5M Cumulative Funding
- 2012$10M Cumulative Funding
- 2023Entered Top 10% NationallyRanked #1913